BR0210195A - Arylazo-substituted imidazole for the treatment of stress urinary incontinence - Google Patents

Arylazo-substituted imidazole for the treatment of stress urinary incontinence

Info

Publication number
BR0210195A
BR0210195A BR0210195-5A BR0210195A BR0210195A BR 0210195 A BR0210195 A BR 0210195A BR 0210195 A BR0210195 A BR 0210195A BR 0210195 A BR0210195 A BR 0210195A
Authority
BR
Brazil
Prior art keywords
treatment
urinary incontinence
arylazo
substituted imidazole
stress urinary
Prior art date
Application number
BR0210195-5A
Other languages
Portuguese (pt)
Inventor
Robert William Gristwood
David Cavalla
Original Assignee
Robert Edward Perry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Edward Perry filed Critical Robert Edward Perry
Publication of BR0210195A publication Critical patent/BR0210195A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"IMIDAZOL SUBSTITUìDO COM ARILAZO PARA O TRATAMENTO DA INCONTINêNCIA URINáRIA POR TENSãO". Um imidazol substituído com arilazo tendo atividade de estimulação alfa adrenérgica é útil para o tratamento da incontinência urinária por tensão."IMIDAZOLE REPLACED WITH ARILAZO FOR TREATMENT OF URINARY INCONTINENCE BY VOLTAGE". An arylazo-substituted imidazole having alpha adrenergic stimulation activity is useful for the treatment of stress urinary incontinence.

BR0210195-5A 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence BR0210195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0114008.6A GB0114008D0 (en) 2001-06-08 2001-06-08 New therapautic use
PCT/GB2002/002635 WO2002100414A1 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence

Publications (1)

Publication Number Publication Date
BR0210195A true BR0210195A (en) 2004-07-27

Family

ID=9916211

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210195-5A BR0210195A (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence

Country Status (13)

Country Link
US (1) US20040242547A1 (en)
EP (1) EP1399167A1 (en)
JP (1) JP2005500285A (en)
KR (1) KR20040030654A (en)
CN (1) CN1234367C (en)
AU (1) AU2002311445B2 (en)
BR (1) BR0210195A (en)
CA (1) CA2449957A1 (en)
GB (1) GB0114008D0 (en)
MX (1) MXPA03011226A (en)
RU (1) RU2004100228A (en)
WO (1) WO2002100414A1 (en)
ZA (1) ZA200309473B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056123B2 (en) * 1979-07-30 1985-12-09 持田製薬株式会社 Agent for treating edema, hypotension, heart failure, and mucosal hyperemia
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence
US6323231B1 (en) * 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence

Also Published As

Publication number Publication date
KR20040030654A (en) 2004-04-09
US20040242547A1 (en) 2004-12-02
ZA200309473B (en) 2005-03-23
EP1399167A1 (en) 2004-03-24
GB0114008D0 (en) 2001-08-01
AU2002311445B2 (en) 2005-08-25
JP2005500285A (en) 2005-01-06
RU2004100228A (en) 2005-06-10
CA2449957A1 (en) 2002-12-19
CN1541099A (en) 2004-10-27
CN1234367C (en) 2006-01-04
WO2002100414A1 (en) 2002-12-19
MXPA03011226A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
DE60233212D1 (en) IMMUNOSTIMULATING COATING FOR SURGICAL DEVICES
BR9608049A (en) Use of alpha 1l agonists for the treatment of urinary incontinence
BR0311591A (en) 1- (aminoalkyl) -2-sulfonylazindoles as 5-hydroxytryptamine-6 ligands
BR0309278A (en) Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound
DE60013250D1 (en) Phenylharnstoffe und phenylthioharnstoffe als orexinrezeptorantagonisten
DE69724811D1 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
TR200200706T2 (en) The use of retigabine for the treatment of neuropathic pain.
CY1105705T1 (en) INDOLLYLALKYLAMINE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LINKERS
BRPI0414794A (en) substituted oxadiazolidinediones
DE60044335D1 (en) 16-PHENOXY-LIPOXIN ANALOGS FOR MEDICAL USE
UY26677A1 (en) HETERO CYCLES THAT ARE INHIBITORS OF THE IMPDH ENZYME
ES2134929T3 (en) PIRROLO-PIRIDINA DERIVATIVES AS LINKS FOR DOPAMINE RECEPTORS.
BR0213072A (en) Bar soap
BR9805151A (en) Nucleic acid constructions for gene therapy whose activity is affected by cyclin-dependent kinase inhibitors.
ATE439363T1 (en) IMIDAZO 2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
BR0307903A (en) arylsulfone derivatives
DE60015508D1 (en) C-16 UNSATURATED FP-SELECTIVE PROSTAGLANDIN ANALOG
DE69934294D1 (en) USE OF AN ANTIMICROBIAL AGENT SUCH AS TAUROLIDINE OR TAURULTAM FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING NOSOCOMIAL MICROBIAL INFECTION
DK1353948T3 (en) Soluble biological analogs for beta-amyloid peptide
BR0210195A (en) Arylazo-substituted imidazole for the treatment of stress urinary incontinence
BR0115882A (en) Use of 1-phenyl-3-dimethylaminopropane compounds in the treatment of urinary incontinence
ATE314058T1 (en) USE OF 5HT3 ANTAGONISTS FOR FUNDUS RELAXATION
BR0015781A (en) Pharmaceutical composition for treatment of diseases associated with decreased bone mass
BRPI0409586A (en) hydroxamic acids useful in treating hyperproliferative disorders
BR0206918A (en) Use of iloperidone

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ARACHNOVA THERAPEUTICS LTD. (GB), SOSEI CO. LTD (JP)

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011.